Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$3,255,253
+$794,869 QoQ
Shares Held
2,714
+1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.82%
of 13F equity value
Holder Rank
#2,052
of 4,605 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Probity Advisors, Inc. holds $17,628,696 across 10 Drug Manufacturers - General names. LLY ranks #1 (18.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
2,714 | $3,255,253 | |
| 2 | ABBV |
AbbVie Inc.
|
12,209 | $3,072,272 | |
| 3 | MRK |
Merck & Co., Inc.
|
19,934 | $2,561,519 | |
| 4 | JNJ |
Johnson & Johnson
|
9,274 | $2,355,317 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,128 | $1,532,251 | |
| 6 | GSK |
GSK plc
|
24,377 | $1,277,842 | |
| 7 | PFE |
Pfizer Inc
|
50,988 | $1,227,791 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
20,006 | $1,152,745 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,255,253 | 2,714 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $2,460,384 | 2,675 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,980,087 | 2,773 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $2,408,028 | 3,156 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $2,515,543 | 3,227 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,707,332 | 3,278 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,659,540 | 3,445 | Shares | Sole | 2025-03-05 | |
| 2024-09-30 | $3,240,768 | 3,658 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $3,615,182 | 3,993 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,419,912 | 4,396 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,781,111 | 4,771 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,739,900 | 5,101 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,462,145 | 5,250 | Shares | Sole | 2023-08-10 | |
| 2022-12-31 | $2,074,678 | 5,671 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $2,064,266 | 6,384 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,274,473 | 7,015 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,069,595 | 7,227 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,207,274 | 7,991 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,969,470 | 8,524 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $2,069,581 | 9,017 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,839,056 | 9,844 | Shares | Sole | 2021-04-28 | |
| 2020-09-30 | $1,664,040 | 11,242 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,948,980 | 11,871 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $1,699,597 | 12,252 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||